Description

Modlin et al proposed a score and a nomogram for predicting survival in a patient with a neuroendocrine tumor of the small intestine. This can help to identify a patient who may benefit from more aggressive management or trial of a novel therapy. The authors are from Yale University, Norwegian University of Science and Technology in Trodheim and the Universitatsmedizin Berlin.


 

Patient selection: neuroendocrine tumor of the small intestine

 

Parameters:

(1) age

(2) gender

(3) race

(4) symptoms at diagnosis

(5) urinary 5-HIAA

(6) serum chromogranin A

(7) liver function tests

(8) carcinoid heart disease

(9) tumor size in cm

(10) tumor stage

(11) tumor grade

(12) Ki-67 index

(13) liver metastases

(14) hepatic surgery to resect metastases

(15) somatostatin therapy

Age

Points

20 to 40 years

(0.004 * ((age)^2)) – (0.112 * (age)) + 2.17

40 to 75 years

(0.01206 * ((age)^2)) – (0.873 * (age)) + 19.78

 

 

Parameter

Finding

Points

gender

male

4

 

female

0

race

white

0

 

black

4

 

other

8

symptoms at diagnosis

no

0

 

yes

32

urinary 5-HIAA

normal

0

 

elevated

4

serum chromogranin A

normal

0

 

elevated

8

liver function tests

normal

0

 

elevated

 

carcinoid heart disease

no

0

 

yes

8

tumor size

< 2 cm

0

 

2 to 2.5 cm

8

 

> 2.5 cm

12

tumor stage

local

0

 

regional spread

4

 

distant metastases

12

tumor grade

Grade I

4

 

Grade II

8

 

Grade III

12

 

Grade IV

16

Ki-67 index

< 5%

0

 

5 to 10%

20

 

> 10%

100

liver metastases

no

0

 

yes

8

hepatic surgery

no

8

 

yes

0

somatostatin therapy

no

12

 

yes

0

 

total score =

= SUM(points for all of the parameters)

 

Interpretation:

• minimum score: 5.5 (age 20, Grade I)

• maximum score: > 200

• The higher the score the worse the prognosis.

 

Score

Percent with 10 Year Survival

< 10

> 76%

10 to 50

(-0.1 * (points)) + 77

50 to 100

(-0.01659 * ((points)^2)) + (1.513 * (points)) + 37.98

100 to 150

(-0.275 * (points)) + 51.5

> 150

< 8%

 


To read more or access our algorithms and calculators, please log in or register.